Scanogen Inc.
Milford Mill, MD
- UEI
- JK9PMLM41J77
- CAGE
- 6NSE7
- Primary NAICS
- 339113 Surgical Appliance and Supplies Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 339112 Surgical and Medical Instrument Manufacturing
- 541713 Research and Development in Nanotechnology
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration date
- Physical address
- 2525 Lord Baltimore Dr Ste. M, Windsor Mill, MD 21244, USA
- Website
- scanogen.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Scanogen Inc. is a minority-owned, Hispanic American-owned small business located in Windsor Mill, Maryland, focused on developing advanced molecular diagnostic technologies for medical applications. The company specializes in innovative single molecule detection platforms, particularly for rapid pathogen identification in clinical settings. Registered in SAM.gov since 2012, Scanogen has positioned itself as a cutting-edge biotechnology firm developing diagnostic solutions that address critical challenges in medical testing, with a primary emphasis on rapidly identifying infectious agents directly from whole blood samples.
Scanogen has been awarded multiple federal grants from the National Institute of Allergy and Infectious Diseases (NIAID), consistently focusing on developing advanced diagnostic technologies for bloodstream infections and sepsis. Their primary research has centered on Single Molecule Tethering (SMOLT), a novel molecular detection technology designed to identify pathogens quickly and accurately. Specific grant-funded projects include developing an automated platform for yeast identification in whole blood, creating a multiplex assay for detecting 13 bloodstream microbes, designing a rapid identification and antimicrobial susceptibility testing platform, and creating a culture and amplification-free bacterial sepsis diagnostic tool. Each project aims to dramatically reduce diagnostic times from traditional blood culture methods, with detection limits ranging from 0.5 to 10 CFU/mL and turnaround times as short as 70 minutes. The research goals consistently emphasize improving patient outcomes by enabling faster, more targeted treatment of life-threatening infections.
SBA capabilities narrative
Research and development in Biotechnology
Quick answers
Is Scanogen Inc. registered in SAM.gov?
Yes. Scanogen Inc.'s SAM.gov registration is active through September 28, 2027.
What is Scanogen Inc.'s CAGE code?
Scanogen Inc.'s CAGE code is 6NSE7, and its Unique Entity ID (UEI) is JK9PMLM41J77.
What is Scanogen Inc.'s most recent federal award?
Scanogen Inc.'s most recent federal grant award is Bloodstream infection detection directly on whole blood summary yeast bloodstream infections are life-threatening… (SB1AI192001), from National Institute of Allergy and Infectious Diseases (NIH), on September 17, 2025.
On GovTribe
See Scanogen Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors